Company Information

Stock Code    長江生命科技集團有限公司 Code:  00775 CK LIFE SCIENCES INT'L., (HOLDINGS) INC. Website： http://www.ck-lifesciences.com Income Statement   2025/12 HKD($) Change 2024/12 HKD($) 2023/12 HKD($) Turnover 5,410,228,000 -2.036% 5,522,674,000 5,322,733,000 Operating Profit / (Loss) (18,370,000) -- (91,630,000) 68,251,000 Exceptional Items -- -- -- -- Profit / (Loss) of Associated Co. & Jointly Controlled Entity 359,000 142.568% 148,000 333,000 Profit / (Loss) before Taxation (18,011,000) -- (91,482,000) 68,584,000 Taxation (170,436,000) -- (35,072,000) (51,334,000) Minority Interests 1,641,000 -- 0 0 Profit / (Loss) Attributable to Shareholders (186,806,000) -- (126,554,000) 17,250,000   Net Interest Income / (Expense) (245,690,000) -- (323,289,000) (309,246,000) Depreciation & Amortization 245,316,000 0.064% 245,158,000 233,741,000 Directors Remuneration 39,155,000 16.467% 33,619,000 25,957,000   EPS / (LPS) (cts) (1.940) -- (1.320) 0.180 DPS (cts) 0.000 -- 0.000 0.000   Dividend Payout Ratio (%) -- -- -- 0.000% NBV Per Share ($) 0.393 7.634% 0.365 0.436 Financial Ratio   2025/12 HKD($) Change 2024/12 HKD($) 2023/12 HKD($) Operating Margin (%) (0.340)% -- (1.659)% 1.282% Interest Coverage Ratio (x) 0.933 -- 0.729 1.213 ROAA (%) (1.651)% -- (1.149)% 0.153% ROAE (%) (5.124)% -- (3.287)% 0.413%   Copyright ET Net Limited. All rights reserved. Use of this site signifies your agreement to the terms of use. DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.